Department of Health and Human Services September 23, 2009 – Federal Register Recent Federal Regulation Documents

National Institute on Aging; Notice of Closed Meetings
Document Number: E9-22980
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting
Document Number: E9-22979
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting
Document Number: E9-22978
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings
Document Number: E9-22977
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting
Document Number: E9-22976
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
Government-Owned Inventions; Availability for Licensing
Document Number: E9-22975
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Government-Owned Inventions; Availability for Licensing
Document Number: E9-22974
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
National Institute of Mental Health; Notice of Closed Meeting
Document Number: E9-22973
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of Closed Meeting
Document Number: E9-22971
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: E9-22970
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of Closed Meeting
Document Number: E9-22969
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
Proposed Comment Request for Review of ACF Disaster Case Management Implementation Guide; Office of Human Services Emergency Preparedness and Response
Document Number: E9-22946
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
In accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104-13, May 22, 1995), this notice announces that the Administration for Children and Families (ACF), Office of Human Services Emergency Preparedness and Response (OHSEPR) intends to submit to notice in the Federal Register for comments on the ACF Disaster Case Management Implementation Guide, dated December 10, 2008.
Proposed Information Collection Activity; Comment Request
Document Number: E9-22897
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Task Force on Community Preventive Services
Document Number: E9-22885
Type: Notice
Date: 2009-09-23
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Current Good Manufacturing Practice Requirements for Combination Products
Document Number: E9-22850
Type: Proposed Rule
Date: 2009-09-23
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or agency) proposes to codify the current good manufacturing practice (cGMP) requirements applicable to combination products. This proposed rule is intended to promote the public health by clarifying which cGMP requirements apply when drugs, devices, and biological products are combined to create a combination product. In addition, the proposed rule sets forth a transparent and streamlined regulatory framework for firms to use when demonstrating compliance with cGMP requirements for ``single-entity'' and ``co-packaged'' combination products.
Availability of Grant Funds for the Support of Cooperative Agreement Award to Georgetown University Entitled: Genome Wide Methylation Arrays for Detecting Markers of Increased Susceptibility to Mammary Cancer Caused by In-Utero Exposures to Endocrine Disruptors (U01)
Document Number: E9-22848
Type: Notice
Date: 2009-09-23
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and Office of New Animal Drugs (ONADE) is announcing the availability of grant funds for the support of a sole source, cooperative agreement award to Georgetown University, Lombardi Cancer Research Center and Department of Oncology entitled: ``Genome Wide Methylation Arrays for Detection Markers of Increased Susceptibility to Mammary Cancer Caused by In-Utero Exposures to Endocrine Disruptors (U01).'' The main purpose of this study is to help gain an understanding of the extent to which exposures to endocrine disruptors early in life increase later susceptibility to developing breast cancer by inducing heritable epigenetic changes in transcription factors, which are linked to increased breast cancer risk. The study is subject to the requirements of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 331, et seq.) regulations issued under it and applicable Department of Health and Human Services statutes and regulations.
National Center for Complementary & Alternative Medicine; Notice of Closed Meeting
Document Number: E9-22739
Type: Notice
Date: 2009-09-23
Agency: Department of Health and Human Services, National Institutes of Health
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.